Skip to main content
Caplight Logo









Lir Therapeutics

Lir Therapeutics

Private
LondonHealthcare & Life Scienceshttps://www.lirtx.com/

Total Funding Raised

$3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Lir Therapeutics is a biotechnology company that develops AI-driven viral-vector engineering technologies for gene therapy applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

gene therapyviral vectorsadeno-associated virusAAVviral capsid engineeringAI drug discoveryprotein language modelslab-in-the-loopbiotech AIin silico designprecision medicinedrug delivery platformgenerative biologysynthetic biologybiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lir Therapeutics Comparables

Compare Lir Therapeutics with similar companies based on industry and business-model similarity.

Lir Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WhiteLab Genomics
86%
Byongen Therapeutics
86%
Dyno Therapeutics
86%

Lir Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Killian Hanlon

CEO Chief Scientist

Executive Team

Lir Therapeutics Investors

Notable investors and investment history

Lir Therapeutics investors
InvestorRounds
Cell and Gene Therapy CatapultSeed
Amino CollectiveSeed
Fly VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 62% MoM, from 1.8K to 2.9K.

  • Jul 18, 2026

    Grew 43% QoQ from 7 to 10 employees.

Recent news

Latest coverage and updates

  • is_developingAug 18, 2026

    Lirtx is developing adeno-associated virus capsids on Aug 18th '26.

Lir Therapeutics Filings

Explore SEC and related filing metadata, where available.

Lir Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lir Therapeutics's valuation, stock price, and market status.

Is Lir Therapeutics a public or private company?

Lir Therapeutics is a private company.

What is the current stock price of Lir Therapeutics?

Lir Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Lir Therapeutics worth (valuation)?

Valuation information for Lir Therapeutics is not publicly available.

Can I buy Lir Therapeutics stock?

Lir Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lir Therapeutics's last funding round?

Funding round information for Lir Therapeutics is not publicly available.

Who are the main investors in Lir Therapeutics?

Key investors in Lir Therapeutics include Cell and Gene Therapy Catapult, Amino Collective, Fly Ventures.

Will Lir Therapeutics IPO soon?

No public IPO plans have been announced for Lir Therapeutics.

How can I track Lir Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lir Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range8
Year Founded2024
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?